These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 11573850
1. Unanticipated plasma concentrations in two clozapine-treated patients. Alfaro CL, McClure RK, Vertrees JE, Benavides R. Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850 [Abstract] [Full Text] [Related]
3. Clozapine dosages and plasma drug concentrations. Chang WH, Lin SK, Lane HY, Hu WH, Jann MW, Lin HN. J Formos Med Assoc; 1997 Aug; 96(8):599-605. PubMed ID: 9290269 [Abstract] [Full Text] [Related]
5. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia AG, Ventimiglia A, Perucca E. Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421 [Abstract] [Full Text] [Related]
6. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. VanderZwaag C, McGee M, McEvoy JP, Freudenreich O, Wilson WH, Cooper TB. Am J Psychiatry; 1996 Dec; 153(12):1579-84. PubMed ID: 8942454 [Abstract] [Full Text] [Related]
7. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Mauri MC, Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR. Clin Pharmacokinet; 2007 Dec; 46(5):359-88. PubMed ID: 17465637 [Abstract] [Full Text] [Related]
8. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. Xiang YQ, Zhang ZJ, Weng YZ, Zhai YM, Li WB, Cai ZJ, Tan QR, Wang CY. Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698 [Abstract] [Full Text] [Related]
11. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. Llorca PM, Lancon C, Disdier B, Farisse J, Sapin C, Auquier P. J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974 [Abstract] [Full Text] [Related]
12. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data. Ulrich S, Baumann B, Wolf R, Lehmann D, Peters B, Bogerts B, Meyer FP. Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740 [Abstract] [Full Text] [Related]
13. Whole saliva and plasma levels of clozapine and desmethylclozapine. Dumortier G, Lochu A, Zerrouk A, Van Nieuwenhuyse V, Colen de Melo P, Roche Rabreau D, Degrassat K. J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110 [Abstract] [Full Text] [Related]
14. Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram. Perry PJ, Bever KA, Arndt S, Combs MD. Biol Psychiatry; 1998 Oct 15; 44(8):733-8. PubMed ID: 9798077 [Abstract] [Full Text] [Related]
15. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. Lu ML, Lane HY, Chen KP, Jann MW, Su MH, Chang WH. J Clin Psychiatry; 2000 Aug 15; 61(8):594-9. PubMed ID: 10982203 [Abstract] [Full Text] [Related]
16. A target-dose finding study of clozapine in patients with schizophrenia. Bennett JA, Keck PE. Ann Clin Psychiatry; 1996 Mar 15; 8(1):19-21. PubMed ID: 8743644 [Abstract] [Full Text] [Related]
17. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients. Hermida J, Paz E, Tutor JC. Ther Drug Monit; 2008 Feb 15; 30(1):41-5. PubMed ID: 18223461 [Abstract] [Full Text] [Related]
19. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients. Liu HC, Chang WH, Wei FC, Lin SK, Lin SK, Jann MW. Ther Drug Monit; 1996 Apr 15; 18(2):200-7. PubMed ID: 8721285 [Abstract] [Full Text] [Related]